期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Edema, Enigma: 11 B-Hydroxysteroid Dehydrogenase Type 2 Inhibition by Sweetener “Stevia”
1
作者 Salina Esmail Udaya M. Kabadi 《Open Journal of Endocrine and Metabolic Diseases》 2012年第3期49-52,共4页
Intrduction: Edema, Hypertension and Hypokalemia occur with inhibition of 11 B-Hydroxysteroid Dehydrogenase Type 2 (11B-HSD2) by chronic Licorice ingestion. However, a similar presentation following a chronic use of a... Intrduction: Edema, Hypertension and Hypokalemia occur with inhibition of 11 B-Hydroxysteroid Dehydrogenase Type 2 (11B-HSD2) by chronic Licorice ingestion. However, a similar presentation following a chronic use of another commonly used sweetener “Stevia” is not reported. Objective: To document a first case report of a subject presenting with Edema, Prehypertension and Hypokalemia induced by 11B-HSD2 inhibition induced by chronic ingestion of sweetener stevia. Case Report: 32 year old Caucasian woman presented with generalized edema (feet, hands and face) of over 6 months. She was noted to also manifest Prehypertension (138/88 mmHg) and Hypokalemia (3.4 mM/l). Laboratory tests revealed decline in serum aldosterone and plasma renin activity, an increase in plasma cortisol/cortisone ratio. On persistent interrogation, patient admitted to daily consumption of sweetener stevia for over 9 months. All the presenting manifestations resolved with normalization of the laboratory tests on withdrawal of stevia. Conclusion: This case report indicates that chronic ingestion of sweetener stevia may induce edema, hypertension and hypokalemia via reduced conversion of cortisol into cortisone by inhibition of 11 B-Hydroxysteroid Dehydrogenase Type 2. 展开更多
关键词 EDEMA ENIGMA 11 b-hydroxysteroid DEHYDROGENASE TYPE 2 SWEETENER “Stevia”
暂未订购
分泌蛋白二氢二醇脱氢酶的蛋白组学鉴定及其在非小细胞肺癌中的研究
2
作者 黄凌瑾 陈胜喜 +4 位作者 罗万俊 蒋海河 张位星 林国强 周建华 《肿瘤》 CAS CSCD 北大核心 2008年第1期48-52,共5页
目的:鉴定非小细胞肺癌(non-small cell lung cancer,NSCLC)细胞的分泌蛋白,以期为肺癌血清标志物的筛选提供候选分子。方法:培养NSCLC的A549细胞系细胞,收集其培养液中的蛋白,应用蛋白质组学和质谱分析方法鉴定。鉴定的蛋白采用Wester... 目的:鉴定非小细胞肺癌(non-small cell lung cancer,NSCLC)细胞的分泌蛋白,以期为肺癌血清标志物的筛选提供候选分子。方法:培养NSCLC的A549细胞系细胞,收集其培养液中的蛋白,应用蛋白质组学和质谱分析方法鉴定。鉴定的蛋白采用Western印迹进一步验证。收集15例NSCLC癌组织及远处正常肺组织,采用RT-PCR、Western印迹法及免疫组织化学方法检测其在癌组织及肺组织中的表达差异及表达部位。收集血清104例,其中NSCLC患者64例、肺部良性肿瘤20例,健康人20例,应用ELISA检测血清中该分泌蛋白的变化。结果:在A549细胞的培养液中鉴定并证实存在二氢二醇脱氢酶(dihydrodiol dehydrogenase,DDH)。RT-PCR、Western印迹法及免疫组化检测发现:与正常肺组织比较,癌组织中有DDH mRNA和蛋白的高表达(P<0.05),胞质和胞膜中均有DDH蛋白的丰富表达。血清ELISA检测提示,NSCLC患者血清中DDH浓度较肺部良性肿瘤患者及健康人高(P<0.05)。结论:DDH在肺癌组织中高表达,且非小细胞肺癌患者血清中浓度升高,是非小细胞肺癌的分泌蛋白型血清标志物。 展开更多
关键词 3-α-羟甾类脱氢酶(B特异性) 非小细胞肺 生物学标记 血清 蛋白质组学
暂未订购
Inhibition of Forkhead Box 01 Protects Pancreatic beta-Cells against Dexamethasone- Induced Dysfunction 被引量:1
3
作者 Zhang, X. F. Yong, W. +7 位作者 Lv, J.H. Zhu, Y. X. Zhang, J. J. Chen, F. Zhang, R. H. Yang, T. Sun,Y.J. Han, X. 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第11期1618-1618,共1页
关键词 胰腺 转录因子 地塞米松 诱导作用
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部